Brief: Neuroscientific Biopharmaceuticals Ltd Seeks Trading Halt
30/06/2021 02:25
June 30 (Reuters) - NeuroScientific Biopharmaceuticals Ltd
NSB.AX :
* REQUEST TRADING HALT PENDING RESULTS OF CO'S PIVOTAL
SAFETY AND
TOXICITY STUDY
Source text for Eikon: ID:nASX3Jnc3
Further company coverage: NSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO